跳至主要内容
临床试验/JPRN-UMIN000012785
JPRN-UMIN000012785招募中2 期

Feasibility study of adjuvant chemotherapy with TS-1 followed by DCS (DTX+CDDP+S-1) for stage III gastric cancer - Feasibility study of adjuvant chemotherapy with TS-1 followed by DCS (DTX+CDDP+S-1) for stage III gastric cancer

Shimane University Hospital0 个研究点目标入组 30 人开始时间: 2014年1月8日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma, and multicentric cancer. (2) Patients who are contraindicated to S-1, CDDP, and DTX. (3) Patient is taking flucytosine and phenytoin. (4) Patients with the history of severe drug hypersensitivity. (5) Patients with severe complication (intestinal paralysis, intestinal obstruction, interstitial pneumonitis, pulmonary fibrosis, severe diabetes, heart failure, renal failure, liver cirrhosis, liver failure, etc.). (6) Patients with diarrheal disease or watery diarrhea. (7) Pregnant and/or nursing women (8) Patients with positive HBs antigen (9) Any subject judged by the investigator to be unfit for any reason to participate in the study.

研究者

相似试验